Terifrac Solo 600mcg Injection contains Teriparatide, a synthetic version of human parathyroid hormone (PTH). By encouraging the growth of new bone, it is used to treat specific bone disorders.

Brand Name: Terifrac

Composition: Teriparatide

Mechanism of Action:

A recombinant version of parathyroid hormone called teriparatide aids in controlling the metabolism of phosphorus and calcium in bones. It increases bone density and fosters the growth of new bone by stimulating osteoblasts, the cells that make up bone.

Uses:

·         Osteoporosis in Postmenopausal Women

·         Primary or Hypogonadal Osteoporosis in Men

·         Glucocorticoid-Induced Osteoporosis

Dosage and Administration:

Typically, 20mcg once daily is administered as a subcutaneous injection, usually into the thigh or abdomen.

Side Effects:

• Nausea
• Dizziness
• Pain at the injection site
• Hypercalcemia
• Joint pain

Safety Advise: 

Kidney  

Patients with renal impairment may need dose adjustments. Kindly speak with your Healthcare provider.

Liver  

Information about the use of Terifrac Injection in liver disease patients is limited. Kindly speak with your Healthcare provider.

Pregnancy  

Use of Terifrac is generally not recommended during pregnancy. Kindly speak with your Healthcare provider.

Breast Feeding  

Use of Terifrac is generally not recommended during breastfeeding. Kindly speak with your Healthcare provider.

Alcohol  

When taking alcohol with Terifrac Injection, caution is advised. Kindly speak with your Healthcare provider.

How to use this Medication?

This medication is injected subcutaneously. You will learn how to administer and prepare this medication. Use precisely as instructed. Take your medication on a regular basis. Never take your medication more frequently than prescribed.

Your pharmacist will provide you with a unique MedGuide with every prescription and refill. Every time, make sure to carefully read this information.

Consult your pediatrician about the usage of this medication in young patients. There might be a need for extra caution.

References:

1.      Quattrocchi E, Kourlas H. Teriparatide: a review. Clinical therapeutics. 2004 Jun 1;26(6):841-54.

2.      Lindsay R, Krege JH, Marin F, Jin L, Stepan JJ. Teriparatide for osteoporosis: importance of the full course. Osteoporosis international. 2016 Aug;27:2395-410.

3.      Blick SK, Dhillon S, Keam SJ. Teriparatide: a review of its use in osteoporosis. Drugs. 2008 Dec;68:2709-37.

4.      Saag KG, Shane E, Boonen S, Marín F, Donley DW, Taylor KA, Dalsky GP, Marcus R. Teriparatide or alendronate in glucocorticoid-induced osteoporosis. New England Journal of Medicine. 2007 Nov 15;357(20):2028-39.

Disclaimer:

The main goal of Apothecare Wellness is to make sure that the information it provides to customers is correct, reliable, and reviewed by specialists. This website's contents and information are strictly for informational purposes. They are not meant to be used in place of expert medical advice, diagnosis, or care. Please consult your physician for guidance and ask any questions you may have about any condition or medication. If you read anything on Apothecare Wellness, do not discount or delay obtaining competent medical advice. Our goal is to enhance the doctor-patient relationship, not to take its place.

Marketer details

Name: Intas Pharmaceuticals Ltd

Address: Chinubhai Centre, Off. Nehru Bridge, Ashram Road, Ahmedabad - 380009. Gujarat. India.

Country of origin: India